BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Butros LJ, Abramson DH, Dunkel IJ. Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences. Pediatrics 2002;109:E45. [PMID: 11875173 DOI: 10.1542/peds.109.3.e45] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Singh G, Daniels AB. Disparities in Retinoblastoma Presentation, Treatment, and Outcomes in Developed and Less-Developed Countries. Semin Ophthalmol 2016;31:310-6. [PMID: 27127937 DOI: 10.3109/08820538.2016.1154177] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
2 Canty CA. Retinoblastoma: an overview for advanced practice nurses. J Am Acad Nurse Pract 2009;21:149-55. [PMID: 19302690 DOI: 10.1111/j.1745-7599.2008.00378.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kamihara J, Bourdeaut F, Foulkes WD, Molenaar JJ, Mossé YP, Nakagawara A, Parareda A, Scollon SR, Schneider KW, Skalet AH, States LJ, Walsh MF, Diller LR, Brodeur GM. Retinoblastoma and Neuroblastoma Predisposition and Surveillance. Clin Cancer Res 2017;23:e98-e106. [PMID: 28674118 DOI: 10.1158/1078-0432.CCR-17-0652] [Cited by in Crossref: 96] [Cited by in F6Publishing: 34] [Article Influence: 32.0] [Reference Citation Analysis]
4 Ozdemir H, Tacyildiz N, Unal E, Yavuz G, Ugur H, Gunduz K. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center. Pediatr Hematol Oncol 2007;24:221-31. [PMID: 17454793 DOI: 10.1080/08880010601107623] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
5 Handayani K, Indraswari BW, Sitaresmi MN, Mulatsih S, Widjajanto PH, Kors WA, Kaspers GJ, Mostert S. Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia. Asian Pac J Cancer Prev 2021;22:1613-21. [PMID: 34048193 DOI: 10.31557/APJCP.2021.22.5.1613] [Reference Citation Analysis]
6 Yousef YA, Mohammad M, Mehyar M, Sultan I, Al-Hussaini M, Alhourani J, Halalsheh H, Khzouz J, Jaradat I, Qaddoumi I, Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. J Pediatr Hematol Oncol 2021;43:e841-7. [PMID: 33769386 DOI: 10.1097/MPH.0000000000002144] [Reference Citation Analysis]
7 Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, Hamilton W, Hendry A, Hendry M, Lewis R, Macleod U, Mitchell ED, Pickett M, Rai T, Shaw K, Stuart N, Tørring ML, Wilkinson C, Williams B, Williams N, Emery J. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015;112 Suppl 1:S92-107. [PMID: 25734382 DOI: 10.1038/bjc.2015.48] [Cited by in Crossref: 366] [Cited by in F6Publishing: 307] [Article Influence: 61.0] [Reference Citation Analysis]
8 Mattosinho CCS, Moura ATMS, Oigman G, Ferman SE, Grigorovski N. Time to diagnosis of retinoblastoma in Latin America: A systematic review. Pediatr Hematol Oncol 2019;36:55-72. [PMID: 31014139 DOI: 10.1080/08880018.2019.1605432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Traoré F, Sylla F, Togo B, Kamaté B, Diabaté K, Diakité AA, Diall H, Dicko F, Sylla M, Bey P, Desjardins L, Gagnepain-lacheteau A, Coze C, Harif M, Doz F. Treatment of retinoblastoma in Sub-Saharan Africa: Experience of the paediatric oncology unit at Gabriel Toure Teaching Hospital and the Institute of African Tropical Ophthalmology, Bamako, Mali. Pediatr Blood Cancer 2018;65:e27101. [DOI: 10.1002/pbc.27101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Brasme JF, Morfouace M, Grill J, Martinot A, Amalberti R, Bons-Letouzey C, Chalumeau M. Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits. Lancet Oncol 2012;13:e445-59. [PMID: 23026830 DOI: 10.1016/S1470-2045(12)70361-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 20] [Article Influence: 10.4] [Reference Citation Analysis]
11 Ferrari A, Miceli R, Casanova M, Meazza C, Favini F, Luksch R, Catania S, Fiore M, Morosi C, Mariani L. The symptom interval in children and adolescents with soft tissue sarcomas. Cancer 2010;116:177-83. [PMID: 19862818 DOI: 10.1002/cncr.24695] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
12 Ramírez-Ortiz MA, Ponce-Castañeda MV, Cabrera-Muñoz ML, Medina-Sansón A, Liu X, Orjuela MA. Diagnostic delay and sociodemographic predictors of stage at diagnosis and mortality in unilateral and bilateral retinoblastoma. Cancer Epidemiol Biomarkers Prev 2014;23:784-92. [PMID: 24521997 DOI: 10.1158/1055-9965.EPI-13-1069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
13 Hilkert SM, Farooq AV, Greenwald MJ. Retinoblastoma: A Global Perspective. Curr Ophthalmol Rep 2017;5:119-27. [DOI: 10.1007/s40135-017-0138-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Weaver MS, Heminger CL, Lam CG. Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes. BMC Public Health 2014;14:944. [PMID: 25213666 DOI: 10.1186/1471-2458-14-944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
15 Kaliki S, Ji X, Zou Y, Rashid R, Sultana S, Taju Sherief S, Cassoux N, Y Diaz Coronado R, Luis Garcia Leon J, López AMZ, Polyakov VG, Ushakova TL, Rani Roy S, Ahmad A, Al Harby L, Reddy MA, Sagoo MS, L Berry J, Kim J, Polski A, Astbury NJ, Bascaran C, Blum S, Bowman R, Burton MJ, Foster A, Gomel N, Keren-Froim N, Madgar S, W Stacey A, M Steinberg D, Mohamed A, Zondervan M, Fabian ID. Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries. Cancers (Basel) 2021;13:1956. [PMID: 33921566 DOI: 10.3390/cancers13081956] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Epelman S. Preserving Vision in Retinoblastoma Through Early Detection and Intervention. Curr Oncol Rep 2012;14:213-9. [DOI: 10.1007/s11912-012-0226-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
17 Rivas-Perea P, Baker E, Hamerly G, Shaw BF. Detection of leukocoria using a soft fusion of expert classifiers under non-clinical settings. BMC Ophthalmol 2014;14:110. [PMID: 25204762 DOI: 10.1186/1471-2415-14-110] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
18 Bai S, Ren R, Li B, Xu X, Zhao B, Gao F, Li L, Jonas JB. Delay in the diagnosis of retinoblastoma in China. Acta Ophthalmologica 2011;89:e72-4. [DOI: 10.1111/j.1755-3768.2010.01930.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
19 Nyamori JM, Kimani K, Njuguna MW, Dimaras H. Retinoblastoma referral pattern in Kenya. Middle East Afr J Ophthalmol 2014;21:321-7. [PMID: 25371638 DOI: 10.4103/0974-9233.142270] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
20 Lin FY, Chintagumpala MM. Neonatal Retinoblastoma. Clin Perinatol 2021;48:53-70. [PMID: 33583507 DOI: 10.1016/j.clp.2020.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Goyal S, Roscoe J, Ryder W, Gattamaneni H, Eden T. Symptom interval in young people with bone cancer. European Journal of Cancer 2004;40:2280-6. [DOI: 10.1016/j.ejca.2004.05.017] [Cited by in Crossref: 79] [Cited by in F6Publishing: 60] [Article Influence: 4.6] [Reference Citation Analysis]
22 Cecen E, Gunes D, Mutafoglu K, Sarialioglu F, Olgun N. The time to diagnosis in childhood lymphomas and other solid tumors: The Time to Diagnosis in Childhood Cancer. Pediatr Blood Cancer 2011;57:392-7. [DOI: 10.1002/pbc.23072] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
23 Posner M, Jaulim A, Vasalaki M, Rantell K, Sagoo MS, Reddy MA. Lag time for retinoblastoma in the UK revisited: a retrospective analysis. BMJ Open 2017;7:e015625. [PMID: 28710216 DOI: 10.1136/bmjopen-2016-015625] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Lukamba RM, Yao JA, Kabesha TA, Budiongo AN, Monga BB, Mwembo AT, Bey P, Chenge GB, Desjardins L, Luboya ON, Doz F, Stefan CD. Retinoblastoma in Sub-Saharan Africa: Case Studies of the Republic of Côte d'Ivoire and the Democratic Republic of the Congo. J Glob Oncol 2018;4:1-8. [PMID: 30241234 DOI: 10.1200/JGO.17.00056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A. Delays in Cancer Diagnosis in Underinsured Young Adults and Older Adolescents. The Oncologist 2007;12:816-24. [DOI: 10.1634/theoncologist.12-7-816] [Cited by in Crossref: 117] [Cited by in F6Publishing: 106] [Article Influence: 8.4] [Reference Citation Analysis]
26 Dang-tan T, Franco EL. Diagnosis delays in childhood cancer: A review. Cancer 2007;110:703-13. [DOI: 10.1002/cncr.22849] [Cited by in Crossref: 127] [Cited by in F6Publishing: 94] [Article Influence: 9.1] [Reference Citation Analysis]
27 Rojanaporn D, Attaseth T, Dieosuthichat W, Leelawongs K, Pakakasama S, Anurathapan U, Chanthanaphak E, Singhara Na Ayudhaya S, Aroonroch R, Hongeng S. Clinical Presentations and Outcomes of Retinoblastoma Patients in relation to the Advent of New Multimodal Treatments: A 12-Year Report from Single Tertiary Referral Institute in Thailand. J Ophthalmol 2020;2020:4231841. [PMID: 33005446 DOI: 10.1155/2020/4231841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chawla B, Singh R. Recent advances and challenges in the management of retinoblastoma. Indian J Ophthalmol 2017;65:133-9. [PMID: 28345569 DOI: 10.4103/ijo.IJO_883_16] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 4.8] [Reference Citation Analysis]
29 Mattosinho C, Moura AT, Grigorovski N, Araújo LH, Ferman S, Ribeiro K. Socioeconomic status and retinoblastoma survival: Experience of a tertiary cancer center in Brazil. Pediatr Blood Cancer 2021;68:e28757. [PMID: 33089657 DOI: 10.1002/pbc.28757] [Reference Citation Analysis]
30 Canadian Retinoblastoma Society. National Retinoblastoma Strategy Canadian Guidelines for Care: Stratégie thérapeutique du rétinoblastome guide clinique canadien. Can J Ophthalmol 2009;44 Suppl 2:S1-88. [PMID: 20237571 DOI: 10.3129/i09-194] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
31 Toli A, Perente A, Labiris G. Evaluation of the red reflex: An overview for the pediatrician. WJM 2021;11:263-77. [DOI: 10.5662/wjm.v11.i5.263] [Reference Citation Analysis]
32 Aguirre Neto JCD, Antoneli CBG, Ribeiro KB, Castilho MS, Novaes PERS, Chojniak MMM, Arias V. Retinoblastoma in children older than 5 years of age. Pediatr Blood Cancer 2007;48:292-5. [DOI: 10.1002/pbc.20931] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
33 Soliman SE, Dimaras H, Khetan V, Gardiner JA, Chan HS, Héon E, Gallie BL. Prenatal versus Postnatal Screening for Familial Retinoblastoma. Ophthalmology 2016;123:2610-7. [PMID: 27712844 DOI: 10.1016/j.ophtha.2016.08.027] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 8.2] [Reference Citation Analysis]
34 Mattosinho CCS, Grigorovski N, Lucena E, Ferman S, Soares de Moura ATM, Portes AF. Prediagnostic Intervals in Retinoblastoma: Experience at an Oncology Center in Brazil. J Glob Oncol 2017;3:323-30. [PMID: 28831440 DOI: 10.1200/JGO.2016.005595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lueder GT. The Effect of Initial Recognition of Abnormalities by Physicians on Outcome of Retinoblastoma. Journal of American Association for Pediatric Ophthalmology and Strabismus 2005;9:383-5. [DOI: 10.1016/j.jaapos.2005.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey R. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol 2016;100:172-8. [DOI: 10.1136/bjophthalmol-2015-306672] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 7.7] [Reference Citation Analysis]
37 Kiss S, Leiderman YI, Mukai S. Diagnosis, Classification, and Treatment of Retinoblastoma. International Ophthalmology Clinics 2008;48:135-47. [DOI: 10.1097/iio.0b013e3181693670] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
38 Khan AO, Al-mesfer S. Lack of Efficacy of Dilated Screening for Retinoblastoma. J Pediatr Ophthalmol Strabismus 2005;42:205-10. [DOI: 10.3928/01913913-20050701-01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]